Scan how Quaker Chemical's earnings swing compares with peers by lining it up against 38 high quality undervalued stocks that combine solid fundamentals with compressed expectations.
To own Quaker Chemical, you need to be comfortable with a specialty chemicals business that is leaning heavily on volume growth in Asia Pacific, higher value Fluid Intelligence offerings, and a multi year cost transformation to support earnings. The swing from a prior year loss to a nine month profit shows the model can generate income, although Q3 profit stayed roughly flat year on year.
The key near term catalyst remains execution on cost savings and network optimization, which are aimed at lifting EBITDA margins. The biggest near term risk is that raw material and logistics costs, especially for crude linked inputs and shipping routes, stay elevated and keep Americas margins under pressure. The latest quarter does not fundamentally change either side of that equation.
The most relevant update for that thesis is the third quarter 2026 report itself. Sales reached US$544.55 million for the quarter and US$1.56b for the nine months, with net income of US$29.98 million in Q3 and US$76.48 million year to date after a loss in the prior period. That earnings profile gives you a cleaner base to judge the cost program after the earlier one off loss.
In the short term, investors watching Quaker Chemical are likely to focus on how this profitability run rate interacts with the planned US$20m to US$30m structural savings, Asia Pacific capacity from Zhangjiagang, and any lingering Americas cost drag. With debt not well covered by operating cash flow and the dividend not fully backed by free cash, consistent execution on margins and cash generation remains the hinge for the current catalysts.
Quaker Chemical's analyst narrative points to forecast revenue of US$2.3b and expected earnings of US$215.8 million by 2029, based on an assumed 4.6% yearly revenue growth rate and a move in profit from US$97.5 million today to the US$215.8 million consensus, which represents roughly a 2.2x earnings increase.
Uncover why Quaker Chemical's fair value indicates a 28% potential upside to its current price that may not last much longer.
Some of the most optimistic analysts were already leaning hard into the Zhangjiagang expansion as a key upside catalyst for Quaker Chemical, assuming roughly US$2.3b of revenue and about US$216.2 million of earnings by 2029. You now have fresh earnings and a completed buyback that those forecasts did not yet factor in, so it is worth comparing several viewpoints before deciding which story you find most convincing.
Explore 2 other Quaker Chemical fair value estimates, including one that suggests there could be as much as 33% potential upside from the current price.
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so consider trusting your own analysis and judgment.
If you want to stress test your thesis on Quaker Chemical against a wider opportunity set, the Simply Wall St Screener can help you line up other businesses with similar or better fundamentals in a few clicks.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com